ACOR's logo.
Ticker Symbol: ACOR

Acorda Therapeutics Inc

$3.38 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001008848

Company Profile

acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 420 Saw Mill River Rd
CEO: Ron Cohen
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $10.15
Change: -$0.56 ( -5.32%)
Days Range: $10.15 - $10.50
Beta: -1.36
52wk. High: $18.20
52wk. Low: $0.44
Ytd. Change 1218.54%
50 Day Moving Average: $12.98
200 Day Moving Average: $9.85
Shares Outstanding: 1242098

Valuation

Market Cap: 1.3B
PE Ratio: -0.59
EPS (TTM): -17.08

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A